Most individual patents sell for somewhere between $50,000 and $500,000, and the question of how much patents sell for really comes down to a handful of variables: how broad the claims are, whether a buyer can point to products that already infringe, how many years remain before expiration, and what technology sector the patent sits in. Narrow patents near expiration change hands for a few thousand dollars. Patents covering widely adopted technology with proven infringement occasionally clear a million. Asking prices for U.S. issued patents with demonstrable commercial use tend to cluster in the $200,000 to $350,000 range, though actual closing prices vary widely.
Price Tiers for Individual Patents
Patent sale prices fall into rough tiers, and knowing where an asset fits sets realistic expectations before you ever talk to a buyer.
At the low end, patents with narrow claims, limited commercial relevance, or only a few years of remaining life sell for $5,000 to $50,000. These are sometimes called “nuisance value” patents because their main use is creating a modest litigation threat that a potential infringer would rather settle cheaply than fight. Sellers at this tier are often individual inventors who never commercialized the technology.
The middle band runs roughly $100,000 to $500,000. Patents here have solid claims that map to products already on the market. A buyer at this level has typically identified specific companies whose products read on the claims and can build a licensing or enforcement campaign around the asset. These patents usually have at least eight to ten years of remaining life and sit in active technology sectors.
Above $500,000, you’re looking at patents covering foundational technology in high-demand fields like semiconductors, wireless communications, or pharmaceuticals. Individual patents occasionally cross the million-dollar line, but those deals are outliers driven by the patent’s ability to block competitors in a large market. Mean transaction prices across large datasets skew higher than the typical price. One analysis of over 43,000 patent transactions in telecom and IT found an average price near $484,000 per document, though averages get pulled up by a small number of very large deals.
Portfolios Price Differently
When patents sell in bulk, the math shifts. A portfolio of 50 patents rarely fetches 50 times the value of one good patent. Buyers apply a portfolio discount because many individual assets in the bundle have limited standalone value. The strategic appeal of a portfolio is coverage, controlling enough of a technology space that competitors can’t design around you, rather than the strength of any single patent.
Portfolio deals routinely reach tens of millions of dollars for a few hundred assets, but the per-patent price often drops to a fraction of what the best individual patents in the set would command on their own. Sellers who package portfolios intelligently, grouping related patents, providing claim charts for key assets, and documenting the technology landscape, get better prices than those who dump everything into one undifferentiated lot.
What Drives the Sale Price
A handful of factors account for most of the price variation between patents, and experienced buyers evaluate them quickly.
- Claim breadth. Broad, well-drafted independent claims that cover a wide range of implementations are worth far more than narrow claims limited to a specific configuration. The difference between a patent that covers “a wireless device that performs X” and one that covers “a specific chipset manufactured by a specific process that performs X” can be a factor of ten in sale price.
- Evidence of use. A patent with a detailed claim chart showing how a specific commercial product infringes each claim element is dramatically more valuable than one where the technology match is theoretical. Buyers pay for certainty, and claim charts provide it.
- Remaining life. Patents expire 20 years after their earliest effective filing date. A patent with 12 years left gives a buyer over a decade of licensing revenue or competitive protection. One with three years left is worth a fraction of that.
- Technology sector. Patents in sectors with high licensing activity, such as wireless standards, cloud computing, medical devices, and biotechnology, command premiums because there are more potential licensees and a more established market for enforcement. Niche industrial patents with a handful of possible infringers sell for less.
- Legal resilience. A patent that has survived a challenge at the Patent Trial and Appeal Board carries a meaningful premium. Buyers know that any patent they enforce will likely face an invalidity challenge, and one that already weathered that storm is a safer bet. A messy prosecution history with narrow amendments and damaging statements in the file wrapper pushes the price down.
- Forward citations. When later patents cite your patent as prior art, it signals that the technology is foundational. Research from UC Berkeley and the National Bureau of Economic Research found that each additional forward citation per patent correlated with roughly a 3% increase in the patent holder’s market value. Firms with citation counts well above the median showed value premiums of 35% or more.
How Buyers and Sellers Arrive at a Number
When negotiating a price, buyers and sellers typically rely on one of three standard valuation approaches, sometimes blending them.
Cost Approach
The cost approach estimates what it would take to independently develop and patent the same technology from scratch, including R&D expenses, prosecution costs, and inventor compensation. This sets a floor value but consistently underestimates market prices because it ignores demand. A patent that cost $80,000 to develop and prosecute might sell for five times that if it covers widely used technology.
Market Approach
The market approach looks at comparable transactions: what similar patents in the same technology area sold for recently. It’s the most intuitive method but suffers from a data problem, because most patent sales are private and deal terms rarely become public. Analysts piece together pricing signals from patent auctions, SEC filings that disclose IP acquisitions, and brokerage reports. The approach works best in technology sectors with high transaction volumes where enough data points exist to establish a range.
Income Approach
The income approach projects the future revenue a patent will generate through licensing royalties, cost savings from exclusive use, or damages from enforcement, and discounts those future cash flows back to a present value. This is the most common method for high-value patents, particularly in pharmaceuticals and medical devices where revenue streams are more predictable. Analysts have to estimate a reasonable royalty rate, which varies by industry. Academic research on publicly available license agreements has found that royalty rates tend to cluster around 2% to 5% in medical devices and pharmaceuticals, and 3% to 6% in the chemical industry. Software and telecom royalties vary more widely, often landing in the 1% to 5% range depending on whether the patent covers a core function or a peripheral feature.
What Comes Out of the Sale Price
The number on the contract isn’t what lands in your bank account. Several costs eat into the proceeds.
Broker commissions typically run 20% to 40% of the net sale price, with the percentage scaling down for larger deals. On a $300,000 patent sale, that’s $60,000 to $120,000 gone before anything else. Sellers who negotiate directly avoid this cost but often accept lower sale prices due to limited buyer access.
Legal fees for drafting and reviewing the patent purchase agreement, assignment documents, and any ancillary agreements generally run a few thousand dollars for a straightforward single-patent sale, and climb considerably higher for complex portfolio transactions. The warranties and indemnification provisions in a patent purchase agreement create real financial exposure, so attorney involvement isn’t optional.
Maintenance fees must be current for the patent to be enforceable at closing. For large entities, the USPTO’s 2026 fee schedule sets these at $2,150 at the 3.5-year mark, $4,040 at 7.5 years, and $8,280 at 11.5 years. Small entities pay 60% less, and micro entities pay 80% less. If a seller has let maintenance fees lapse, the patent may be dead, or revivable only with a petition and surcharge.1United States Patent and Trademark Office. USPTO Fee Schedule
Then there’s tax. Individual inventors and certain early-stage investors get favorable treatment under federal law. When a “holder”, defined as the individual who created the invention or someone who acquired an interest before the invention was reduced to practice, transfers all substantial rights to a patent, the proceeds are treated as long-term capital gains regardless of holding period. This applies even if payments are structured as periodic royalties tied to the buyer’s use. Long-term capital gains rates in 2026 top out at 20% for the highest earners, compared to ordinary income rates that can reach 37%.2Office of the Law Revision Counsel. 26 U.S. Code 1235 – Sale or Exchange of Patents
This favorable treatment has limits. It applies only to individuals, not corporations. It doesn’t cover transfers between related parties, defined more broadly than usual, with the threshold at 25% ownership rather than the typical 50%. And the seller must transfer “all substantial rights,” so a sale of partial rights or a license restricted to a specific field of use won’t qualify. Corporations that sell patents generally treat the proceeds as ordinary income or Section 1231 gains depending on the circumstances. The structuring choices you make, whether lump sum versus installments or asset sale versus entity sale, directly affect the tax bill.
Where Patents Actually Change Hands
The patent secondary market operates through several channels, each suited to different transaction sizes and seller sophistication.
Patent brokers handle most mid-to-large transactions. A broker identifies potential buyers, prepares marketing materials and claim charts, runs a competitive bidding process, and negotiates terms. This is the most common path for portfolios and high-value individual patents. The tradeoff is the commission, but brokers have buyer networks that individual sellers can’t replicate.
Online marketplaces and auction platforms provide an alternative for sellers who want broader exposure or are dealing with lower-value assets. Auction-format sales create urgency and price discovery but tend to produce lower sale prices than privately negotiated deals.
Direct sales between companies happen frequently in the context of corporate acquisitions, cross-licensing negotiations, or strategic IP purchases. These deals bypass brokers entirely but require the seller to already have a relationship with the buyer or enough market presence that buyers come to them.
Selling Isn’t the Only Option
Before committing to a sale, weigh whether licensing might generate more total revenue. Selling gives you a lump sum and a clean exit: no ongoing management, no enforcement obligations, no uncertainty. It also caps your upside. If the technology turns out to be more valuable than either party anticipated, the buyer captures that surplus.
Licensing preserves your ownership while generating recurring revenue. A well-structured exclusive license in a growing market can produce cumulative royalties that far exceed what an outright sale would have fetched. The downside is that licensing requires ongoing relationship management, enforcement capability if licensees underpay or competitors infringe, and patience, because royalty checks come in gradually rather than all at once. Individual inventors who lack the resources to monitor and enforce a license often find that a clean sale at a fair price beats a licensing program they can’t realistically manage.